Navigation Links
Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer

NEW YORK, April 10, 2007 /PRNewswire-FirstCall/ -- ImClone Systems Incorporated and Bristol-Myers Squibb Company today announced that a Phase III study of ERBITUX(R) (Cetuximab) plus gemcitabine (a chemotherapy) in patients with locally advanced unresectable or metastatic pancreatic cancer did not meet its primary endpoint of improving overall survival.

Conducted by the Southwest Oncology Group (SWOG), a cancer center network sponsored by the National Cancer Institute, the open-label, randomized study compared ERBITUX plus gemcitabine to gemcitabine alone in more than 700 patients with pancreatic cancer in the first-line treatment setting. The study was conducted in centers throughout the United States and Canada. It was completed in a significantly shorter time than projected, providing a timely answer to an important research question. SWOG has informed ImClone and Bristol-Myers Squibb that the primary study endpoint of statistically improving overall survival was not met. The three parties -- SWOG, ImClone, and Bristol-Myers Squibb -- will engage in joint efforts to fully interpret these results.

"This study was designed to examine the Phase II results we previously observed for ERBITUX in patients with pancreatic cancer," stated Eric K. Rowinsky, M.D., Chief Medical Officer and Senior Vice President of ImClone Systems. "We still consider pancreatic cancer to be of the utmost priority and we intend to pursue additional evaluations with ERBITUX including a pilot study of ERBITUX and bevacizumab with or without gemcitabine, as well as our pipeline agents, to improve the outcome for patients with pancreatic cancer."

"Pancreatic cancer is a devastating disease with few effective treatment options, and it is unfortunate that the use of ERBITUX in this trial has not demonstrated the benefit it has shown in other tumors," said Martin Birkhofer, M.D., Vice President, Oncology Global Medical Affa
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
3. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
4. Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
5. Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer
6. Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Alliance Principle Ingredients/Neutrical ... recalling the health product Galenic Health Ginger in ... lead for adolescents and children. The product currently ... children, but within acceptable limits for adult dosing. ... relieve digestive upset and disturbances. Alliance Principle Ingredients ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/64lx2w/north_america_mri ) has announced ... - Growth, Trends And Forecasts (2014 - 2019)" ... MRI systems market is estimated to increase from the ... 2020 with a CAGR of 2.9% between 2014 and ... open system, closed system and the standing or upright ...
(Date:5/29/2015)... 29, 2015  Dr. Yair Walzer has added ... health issues often caused by menopause. The MonaLisa Touch™, an ... received FDA clearance in 2014. Dr. Walzer is one of ... offer the special fractional CO 2 laser specifically designed ... In 2010 there were greater than 46M ...
Breaking Medicine Technology:North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2
... Therapeutics, Inc.,announced the successful completion of a first-in-man ... company is investigating as a,treatment for Rheumatoid Arthritis ... VEL-0230 proved to be a powerful,anti-inflammatory agent that ... together, these characteristics strongly suggest this drug,may be ...
... Inc. (NYSE: CRY ), a,biomaterials, medical device ... of the combination aortic-mitral allograft heart,valve in a ... performed by,Dr. Jose Navia, a cardiac surgeon with ... The method used to process the combination ...
Cached Medicine Technology:Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3
(Date:5/30/2015)... 2015 Boston Scientific Corp. has ... and compensatory damages to a transvaginal mesh lawsuit ... following implantation of the company’s Pinnacle and Advantage ... May 28th in Delaware Superior Court, the plaintiff ... the jury found that the implants were defectively ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 At 73 years ... of vibrant health , which she attributes to a ... principles of good nutrition with the release of her new ... by Xlibris AU). , “Cook for Health and Longevity” features ... nutritious and mostly organic food . It is designed ...
(Date:5/30/2015)... Key Housing, a top-rated corporate housing ... their June 2015 featured apartment community: 388 Beale Street. ... Key Housing is helping those people looking for corporate ... of the tightest apartment markets in the United States. ... anyone who requires temporary San Francisco corporate housing is ...
(Date:5/30/2015)... 30, 2015 Venus Viva has proven ... large pores, deep wrinkles, stretch marks, pigmentation irregularities, and ... such as Dr. F. Victor Rueckl of Lakes Dermatology ... trials in Las Vegas. This body image solution combines ... system that delivers proven results through a skin heating ...
(Date:5/29/2015)... Ready to hit the road? Before embarking on ... get their vehicles ready. With handicapped vehicles, there are even ... (ADS) is ready to help drivers get their handicapped vans ... trips. , When planning for the big trip, drivers should ... trip goes smoothly and they are prepared for all contingencies: ...
Breaking Medicine News(10 mins):Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 2Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 3Health News:Boston Scientific Transvaginal Mesh Lawsuit Trial Ends With $100 Million Verdict 4Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3
... 2007 As schools reopen around the country, a new study ... prevention starting as early as fourth grade. ,A review of ... shows that among typical 4th graders, 10% have already had ... a drink in the past year. While the numbers are ...
... is a,memorandum to editorial writers and columnists:, ... SUBJECT: Katrina Storm Warning, On the ... Orleans,and the Gulf Coast are struggling to rebuild ... in U.S. history. Disaster often strikes suddenly,and with ...
... one-sport specialization are likely culprits behind the increase, , , ... start specializing in one sport early -- playing year-round, ... special training programs -- believing they,ll put themselves on ... a pro sports career. , But for too many ...
... The Mutter Museum will be taking its two Presidential ... the Arden Theater,s ASSASSINS on September 19., PHILADELPHIA, ... Arden Theater will display the actual remains of two,of ... opening,night of the Arden,s production of Assassins, Wednesday, September ...
... Barry Karlin,Chairman and CEO of CRC HEALTH GROUP, ... announced the acquisition of Bayside Marin,Recovery Center (684 ... Located in Marin County, California, Bayside Marin ... The facility has an exceptional,reputation and provides a ...
... 15, 2007, RICHMOND, Va., Aug. 30 While ... and tissue donation in,2006, strongly held myths regarding donation ... becoming organ and tissue donors. In,recognition of Hispanic Heritage ... the Hispanic community, long celebrated for its,zest for life, ...
Cached Medicine News:Health News:Underage drinking starts before adolescence 2Health News:Underage drinking starts before adolescence 3Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 2Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 3Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 4Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 5Health News:More Kids Are Suffering Sports Injuries 2Health News:More Kids Are Suffering Sports Injuries 3Health News:The Mutter Assassins Go to the Theater! 2Health News:The Mutter Assassins Go to the Theater! 3Health News:CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael 2Health News:Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: